Bolt Biotherapeutics, Inc.
Ticker: 1641281
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 0.01-66.7% | 0.03-98.6% | 2.17+20.6% | 1.80+47.5% | 1.22+7.0% | 1.14-10.9% | 1.28-75.7% | 5.27 |
| Total Income | 0.01-66.7% | 0.03-98.6% | 2.17+20.6% | 1.80+47.5% | 1.22+7.0% | 1.14-10.9% | 1.28-75.7% | 5.27 |
| EXPENSES | ||||||||
| Expenditure | 8.38+9.8% | 7.63-22.7% | 9.87-10.4% | 11.01-17.5% | 13.34-24.1% | 17.58-26.4% | 23.87+6.7% | 22.37 |
| PROFIT | ||||||||
| Net Profit | -7.72-6.6% | -7.24-1.4% | -7.14+16.6% | -8.56+22.5% | -11.04+27.3% | -15.18+28.4% | -21.20-96.1% | -10.81 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -4.57-6.0% | -4.31-15.9% | -3.72+16.6% | -4.46-1437.9% | -0.29+27.5% | -0.40+28.6% | -0.56-100.0% | -0.28 |
Corporate Events
Board MeetingBOLT
202623Oct
Board Meeting
Bolt Biotherapeutics, Inc. acquired Prana Therapies, Inc. in…
SEC Filing ↗ Board MeetingBOLT
202610Jun
Board Meeting
2026 Annual Meeting of Stockholders to elect Class II direct…
SEC Filing ↗